Industries > Pharma > Global Burn Care Market Report 2019-2029

Global Burn Care Market Report 2019-2029

Analysis by Product (Advanced, Biologics, Traditional), Depth (Minor, Partial-thickness, Full-thickness Burn), End-Users (Hospitals (Inpatient, Outpatient), Physician Clinics, Homecare), Company, Global Opportunity Analysis by Country and Industry Forecast

PUBLISHED: 05 June 2019
PAGES: 169
PRODUCT CODE: PHA0430
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0430 Categories: , Tag:

Market Definition:
• Burn is an injury to skin or tissue caused due to heat, radiation, electricity, or chemicals.
• In most cases, hot liquids and fire are the common causes of burn, besides which alcoholism, smoking, and violence between people may also lead to burn injuries.
• These wounds are preventable only if few precautions are followed. While superficial burns can be managed by simple pain medications, major burns require prolonged treatment in specialized burn-care centers.

Market Overview and Trends
• Rising demand for minimally invasive procedures and treatments to improve cosmetic appeal is boosting the growth of the Burn Care Market in the upcoming years.
• Rising concern regarding aesthetic appearance among patients is a major factor attributed to the rising demand for the products available in the market are the prominent trends observed in the Burn Care Market.
• Rising demand for skin grafts is also a major growth contributor to spur the demand of Burn Care Market in the forecast year.

Market Dynamics:
Factors Influencing the Market Growth:
• Increasing incidence of burn injuries, and advancements in burn care products, are the key factors to drive the Burn Care Market.
• Increasing awareness level among people regarding the availability of various treatment options for burn care management is anticipated to boost market growth.
Factors Restraining the Market Growth:
• High cost of advanced treatments and products, lack of reimbursement, stringent regulatory requirements may hinder the growth of the market.

Market Segmentation 2019-2029:
The Burn Care Market is segmented on the by product, depth, end-user, and geography

1. Burn Care Market, By Product
a. Advanced
b. Biologics
c. Traditional

2. Burn Care Market, By Depth
a. Minor
b. Partial Thickness
c. Full Thickness

3. Burn Care Market, By End Users
a. Hospitals
b. Physician Clinics
c. Homecare

4. Burn Care Market, By Region
4.1 Introduction
4.2 North America
4.2.1 US
4.2.2 Canada
4.3 Europe
4.3.1 Germany
4.3.2 UK
4.3.3 France
4.3.4 Rest of Europe
4.4 Asia Pacific
4.4.1 Japan
4.4.2 China
4.4.3 India
4.4.4 Rest of Asia Pacific
4.5 Rest of the World (RoW)

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Burn Care Market.
• These companies has developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
• Coloplast A/S, Smith & Nephew plc, Derma Sciences, Inc., Medtronic, Acelity L.P., 3M Company, and Mölnlycke Health Care amongst others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Burn Care Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Burn Care Market Report 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category